From The Lycaeum
Jump to: navigation, search
CAS number 712349-95-6 7pxN
PubChem 9950514
ChemSpider 8126125 7pxY
Jmol-3D images Image 1
Image 2
Molecular formula C14H14INO2
Molar mass 355.17 g/mol
Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
 14pxN (verify) (what is: 10pxY/10pxN?)
Infobox references

3-Iodothyronamine (T1AM) is an endogenous thyronamine. T1AM is a high-affinity ligand for the trace amine-associated receptor TAAR1 (TAR1, TA1), a recently discovered G protein-coupled receptor.[1][2] T1AM is the most potent TAAR1 agonist yet discovered.[3] Activation of TAAR1 by T1AM results in the production of large amounts of cAMP. This effect is coupled with decreased body temperature and cardiac output.[4] Wu et al have pointed out that this relationship is not typical of the endocrine system, indicating that TAAR1 activity may not be coupled to G-proteins in some tissues, or that T1AM may interact with other receptor subtypes.[3]

T1AM may be part of a signaling pathway to modulate cardiac function, as the compound can induce negative inotropic effects and decrease cardiac output.[5]

See also

External links


  1. Scanlan T, Suchland K, Hart M, Chiellini G, Huang Y, Kruzich P, Frascarelli S, Crossley D, Bunzow J, Ronca-Testoni S, Lin E, Hatton D, Zucchi R, Grandy D (2004). "3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone". Nat. Med. 10 (6): 638–42. PMID 15146179. doi:10.1038/nm1051. 
  2. Hart M, Suchland K, Miyakawa M, Bunzow J, Grandy D, Scanlan T (2006). "Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues". J. Med. Chem. 49 (3): 1101–12. PMID 16451074. doi:10.1021/jm0505718. 
  3. 3.0 3.1 Wu SY, Green WL, Huang WS, Hays MT, Chopra IJ (2005). "Alternate Pathways of Thyroid Hormone Metabolism". Thyroid 15 (8): 943–958. PMID 16131336. doi:10.1089/thy.2005.15.943.  edit
  4. "New compound may act to keep thyroid activity in check". Retrieved 2008-05-30. 
  5. Chiellini G, Frascarelli S, Ghelardoni S, Carnicelli V, Tobias SC, Debarber A, Brogioni S, Ronca-Testoni S, Cerbai E, Grandy DK, Scanlan TS, Zucchi R. (2007). "Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function". The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 21 (7): 1597–608. PMID 17284482. doi:10.1096/fj.06-7474com. 
Personal tools

Lycaeum IRC Chat
TheAntiDrug Diaspora
Starting Points